title: Assessing treatment outcome in RLS trials and clinical care: CGI-I, PGI, or VAS?
authors.forename: Birgit
authors.initials: B
authors.lastname: Högl
authors.forename: Viola
authors.initials: V
authors.lastname: Gschliesser
authors.forename: Werner
authors.initials: W
authors.lastname: Poewe
mesh_terms: D052160:Benzothiazoles / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077487:Pramipexole; D012148:Restless Legs Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D052160:Benzothiazoles; D018491:Dopamine Agonists; D000077487:Pramipexole